Immune-Onc Therapeutics Announces Clinical Trial Collaborati

Immune-Onc Therapeutics, Inc. ("Immune-Onc"), a private, clinical-stage biopharmaceutical company dedicated to advancing novel therapies in immunology and oncology by targeting myeloid cell inhibitory receptors, today announced a Phase 1b/2 clinical...

Related Keywords

United States , California , Palo Alto , American , Charlene Liao , Leukemia Lymphoma Society Therapy Acceleration Program , National Cancer Institute , American Cancer Society , California Institute For Regenerative Medicine , Genentech , National Comprehensive Cancer Network , Drug Administration , National Institutes Of Health , Linkedin , Onc Therapeutics Inc , Roche Group , Product Service , American Association For Cancer Research , Randomized Global Phase , First Line Treatment , Advanced Liver , Onc Therapeutics , National Comprehensive Cancer , American Cancer , Cancer Research , Leukocyte Immunoglobulin Like Receptor , National Institutes , California Institute , Regenerative Medicine , Lymphoma Society Therapy Acceleration Program , About Liver , Rev Dis ,